Development of a new class of benzoylpyrrole-based PPARα/γ activators
摘要:
Starting with a subtle blood glucose-lowering effect of a TGF-beta inhibitor, we designed and synthesized a series of benzoylpyrrole-based carboxylic acids as PPARs activators. Among these compounds, 10sNa exhibited favorable blood glucose-lowering effect without body weight gain. We assume that the beneficial effect of 10sNa is attributed to not only its compound PPAR alpha agonistic activity but also its PPAR gamma partial agonistic activity. (C) 2010 Elsevier Ltd. All rights reserved.
Development of a new class of benzoylpyrrole-based PPARα/γ activators
摘要:
Starting with a subtle blood glucose-lowering effect of a TGF-beta inhibitor, we designed and synthesized a series of benzoylpyrrole-based carboxylic acids as PPARs activators. Among these compounds, 10sNa exhibited favorable blood glucose-lowering effect without body weight gain. We assume that the beneficial effect of 10sNa is attributed to not only its compound PPAR alpha agonistic activity but also its PPAR gamma partial agonistic activity. (C) 2010 Elsevier Ltd. All rights reserved.
A novel pyrrole derivative represented by the following formula (1) and a salt thereof:
1
wherein R
1
means substituted alkenyl, etc.; R
2
means substituted benzoyl, etc.; and R
3
to R
5
each means hydrogen, alkyl, halogeno, etc. The derivative and salt have antidiabetic activity.
Starting with a subtle blood glucose-lowering effect of a TGF-beta inhibitor, we designed and synthesized a series of benzoylpyrrole-based carboxylic acids as PPARs activators. Among these compounds, 10sNa exhibited favorable blood glucose-lowering effect without body weight gain. We assume that the beneficial effect of 10sNa is attributed to not only its compound PPAR alpha agonistic activity but also its PPAR gamma partial agonistic activity. (C) 2010 Elsevier Ltd. All rights reserved.